About
Senescence inducing and senolytic compounds
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibody
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
5
As Collaborator
1
Total Enrollment
539
By Phase
NA: 1PHASE2/PHASE3: 1PHASE3: 1
By Status
COMPLETED: 4NOT_YET_RECRUITING: 1RECRUITING: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT07171554Lead Sponsor
Evaluation of a Diagnostic Test to Identify the Best Drugs for Treatment of Metastatic Colorectal Cancer
NANot yet recruiting
75 participants
Started: Sep 30, 2025 · Completed: Jun 30, 2029
NCT05401318Collaborator
Tailoring Treatment in Colorectal Cancer
N/ARecruiting
40 participants
Started: Mar 28, 2022 · Completed: Jan 1, 2027
NCT00561990Lead Sponsor
Nimotuzumab in Adults With Pancreatic Cancer
PHASE2/PHASE3Completed
188 participants
Started: Sep 30, 2007 · Completed: Jan 31, 2014
NCT00753246Lead Sponsor
Nimotuzumab in Adults With Glioblastoma Multiforma
PHASE3Completed
150 participants
Started: Aug 31, 2007 · Completed: Jan 31, 2012
NCT00561691Lead Sponsor
Nimotuzumab in Children With Intrinsic Pontine Glioma
N/ACompleted
41 participants
Started: Apr 30, 2006 · Completed: Jan 31, 2012
Locations (1)
Headquarters
Amsterdam, Netherlands
Map
Loading map...